Ninth Cooley's Anemia Symposium

第九届库利贫血研讨会

• 批准号: 7675533
• 负责人: ELLIOTT P VICHINSKY
• 金额: $ 1万
• 依托单位: NEW YORK ACADEMY OF SCIENCES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7675533
• 关键词: Academy; Address; Adult; Anemia; Basic Science; Biochemistry; Bone Marrow Stem Cell Transplantation; Boston; Cardiac; Cellular biology; Chelation Therapy; Clinical; Clinical Research; Collaborations; Communication; Cooley' s anemia; Disease; Doctor of Philosophy; Educational workshop; Epidemiology; Fetal Hemoglobin; Foundations; Functional disorder; Future; Gene Expression Regulation; Genetic; Goals; Grant; Hematological Disease; Hematology; Hereditary Disease; Image; Individual; Industry; Iron; Iron Overload; Life; Medicine; Metabolism; Molecular Biology; New York; New York City; Participant; Patients; Pediatric Hospitals; Physicians; Play; Postdoctoral Fellow; Principal Investigator; Quality of life; Regulation; Research; Research Personnel; Role; Science; Scientific Advances and Accomplishments; Scientist; Series; Severity of illness; Stem cell transplant; Syndrome; Thalassemia; Transfusion; Work; abstracting; antioxidant therapy; career; chelation; clinical care; family genetics; lectures; meetings; nutrition; oncology; posters; programs; psychosocial; symposium

DESCRIPTION (provided by applicant): The New York Academy of Sciences (NYAS) and Cooley's Anemia Foundation are planning an important 3.5-day conference entitled, "Ninth Cooley's Anemia Symposium." This meeting will be held in October, 21-24, 2009 at the New York Academy of Sciences Conference Center in New York City. The principal investigator for this grant is Elliott Vichinsky MD, Director, Hematology/Oncology at the Children's Hospital and Research Center in Oakland, CA. Co-chair on the scientific organizing committee is Ellis Neufeld, MD, PhD, Associate Chief, Div. Of Hematology/Oncology, Children's Hospital Boston. The scientific goals of the Ninth Cooley's Anemia Symposium involve the presentation and dissemination of current findings, and discussing future directions for basic and clinical research in thalassemia, genetic disorders that cause anemia. The program will address recent advances in: 1) Iron Regulation and Metabolism; 2) Gene Regulation and Therapy; 3) Nutrition and Antioxidant Therapies; 4) Iron Overload and Chelation Therapy; 5) Iron Imaging; 6) New Advances In Stem Cell Transplantation; 7) New Therapy For Hemoglobin F; 8) Cardiac Dysfunction; 9) Clinical Syndromes in Thalassemia and Disease Severity; and 10) The Adult Thalassemia Patient. The symposium will integrate basic science and clinical research so that both bench researchers and clinicians can develop a mutual understanding of recent progress in thalassemia. Participants will include both established and young career scientists, providing a platform for young scientists to enter this field. Furthermore, this conference is expected to increase communication and subsequent collaboration between complimentary research groups. Conference attendees should achieve an understanding of the molecular biology, pathophysiology, epidemiology, clinical care and psychosocial management of thalassemic disorders. A combination of keynote addresses, lectures, workshops, panel discussions, and poster presentations will provide a comprehensive overview of progress in the understanding and treatment of thalassemia. We anticipate that the conference will attract wide participation among senior investigators, post-doctoral fellows, and industry scientists working in the fields of molecular biology, cell biology, hematology, bone marrow & stem cell transplantation, epidemiology, iron biochemistry & chelation, and transfusion medicine. (End of Abstract)

描述（由申请人提供）： 纽约科学院（NYAS）和库利贫血基金会正在计划一个重要的为期3.5天的会议，题为“第九届库利贫血研讨会。“这次会议将于2009年10月21日至24日在纽约市的纽约科学院会议中心举行。该基金的主要研究者是Elliott Vichinsky医学博士，他是加利福尼亚州奥克兰儿童医院和研究中心的血液学/肿瘤学主任。科学组织委员会的联合主席是埃利斯·诺伊菲尔德，医学博士，博士，副主任，分部。波士顿儿童医院血液肿瘤科 第九届库利贫血研讨会的科学目标包括介绍和传播目前的研究结果，并讨论地中海贫血，导致贫血的遗传性疾病的基础和临床研究的未来方向。该计划将讨论最新进展：1）铁调节和代谢; 2）基因调节和治疗; 3）营养和抗氧化治疗; 4）铁过载和螯合治疗; 5）铁成像; 6）干细胞移植的新进展; 7）血红蛋白F的新疗法; 8）心脏功能障碍; 9）地中海贫血的临床综合征和疾病严重程度;和10）成人地中海贫血患者。 研讨会将整合基础科学和临床研究，使实验室研究人员和临床医生可以发展地中海贫血的最新进展的相互理解。与会者将包括成熟的和年轻的职业科学家，为年轻科学家进入这一领域提供一个平台。此外，本次会议预计将增加互补研究小组之间的沟通和随后的合作。 与会者应了解地中海贫血疾病的分子生物学、病理生理学、流行病学、临床护理和心理社会管理。主旨演讲，讲座，研讨会，小组讨论和海报展示相结合，将提供一个全面的地中海贫血的理解和治疗进展的概述。我们预计会议将吸引在分子生物学、细胞生物学、血液学、骨髓和干细胞移植、流行病学、铁生物化学和螯合以及输血医学领域工作的高级研究人员、博士后研究员和行业科学家的广泛参与。(End摘要）